| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -10,250 | -10,250 |
| Effect of foreign exchange rate on cash and cash equivalents | 2,163 | 3,365 |
| Net change in cash and cash equivalents | -25,310 | -19,739 |
| Cash and cash equivalents at beginning of period | 172,677 | - |
| Cash and cash equivalents at end of period | 147,367 | - |
XBiotech Inc. (XBIT)
XBiotech Inc. (XBIT)